BINH DINH PHARMACEUTICAL AND MEDICAL EQUIPMENT JOINT STOCK COMPANY

The subject specializes in manufacturing and trading pharmaceutical products, medical equipment, and materials for pharmaceutical production. The subject has imported materials for pharmaceutical products from many countries, including India, China, Germany, France, South Korea, Taiwan, Bangladesh, the Philippines, etc.

Currently, the company has developed many branches across the country. The distribution system developed strongly from Binh Dinh province, to many provinces of the Central Highlands, and spread to the Northern Area, the Southern Area, and even the Mekong Delta. In recent years, the company has made breakthroughs in the OTC channel by building a professional distribution system in accordance with international standards. It is a partner of 15,000 pharmacies/agents nationwide. Besides the domestic market, its products have been exported to Laos, Mongolia, Yemen and Somalia.

In 2022, the cancer drug factory officially came into operation. Total production output of the subject in 2022 reached 745.7 million products, an increase of 24% compared to the total production output in 2021. In that year, the company submitted new registration documents for 35 products and renewed 36 products, 335 registration dossiers for changes (including 31 injectable cancer drug products registered to change production locations).

Recently, the company announced a resolution on the establishment of a small volume sterile drug factory at "Lot A3.03, A Zone, Nhon Hoi Economic Zone, Nhon Hoi Commune, Quy Nhon City, Binh Dinh Province, Vietnam". The total investment capital of this project is VND 840 billion with a design capacity of 120 million products per year. It is expected to start construction by the end of 2023. On August 17, 2023, the Management Board of Binh Dinh Economic Zone has just decided to approve the investment policy of the company to invest in this factory.